Forum: Articles of Interest
07-14-2014, 01:28 AM
|
Replies: 0
Views: 8,890
High recurrence risk small HER2+ cancers
High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers.
BACKGROUND:
Five randomized trials of adjuvant trastuzumab have ...
|